{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:20:35Z","timestamp":1787019635301,"version":"build-2736575974"},"reference-count":66,"publisher":"American Society of Hematology","issue":"3","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Acute myeloid leukemia (AML) with t(4;12)(q12;p13) translocation is rare and often associated with an aggressive clinical course and poor prognosis. Previous reports based on fluorescence in situ hybridization (FISH) analysis have suggested that ETV6::PDGFRA fusions are present in these patients, despite the absence of eosinophilia, which is typically found in other hematopoietic malignancies with PDGFRA-containing fusions. We first detected an ETV6-SCFD2 fusion by targeted RNA sequencing in a patient with t(4;12)(q12;p13) who had been diagnosed with an ETV6-PDGFRA fusion by FISH analysis but failed to respond to imatinib. We then retrospectively identified 4 additional patients with AML and t(4;12)(q12;p13) with apparent ETV6-PDGFRA fusions using chromosome and FISH analysis and applied targeted RNA sequencing to archival material. We again detected rearrangements between ETV6 and non-PDGFRA 4q12 genes, including SCFD2, CHIC2, and GSX2. None of the 3 patients who received imatinib based on the incorrect assumption of an ETV6-PDGFRA fusion responded. Our findings highlight the importance of using a sequencing-based assay to confirm the presence of targetable gene fusions, particularly in genomic regions, such as 4q12, with many clinically relevant genes that are too close to resolve by chromosome or FISH analysis. Finally, combining our data and review of the literature, we show that sequence-confirmed ETV6-PDGFRA fusions are typically found in eosinophilic disorders (3\/3 cases), and patients with t(4;12)(q12;p13) without eosinophilia are found to have other 4q12 partners on sequencing (17\/17 cases).<\/jats:p>","DOI":"10.1182\/bloodadvances.2021005280","type":"journal-article","created":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T15:16:48Z","timestamp":1632928608000},"page":"818-827","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":11,"title":["t(4;12)(q12;p13) ETV6-rearranged AML without eosinophilia does not involve PDGFRA: relevance for imatinib insensitivity"],"prefix":"10.1182","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7985-2155","authenticated-orcid":false,"given":"Sarah B.","family":"Mueller","sequence":"first","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Dal Cin","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long P.","family":"Le","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dora","family":"Dias-Santagata","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2434-4978","authenticated-orcid":false,"given":"Jochen K.","family":"Lennerz","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. John","family":"Iafrate","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8203-0622","authenticated-orcid":false,"given":"Hetal Desai","family":"Marble","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Brunner","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Massachusetts General Hospital, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Weinstock","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5781-4529","authenticated-orcid":false,"given":"Marlise R.","family":"Luskin","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7865-2306","authenticated-orcid":false,"given":"Daniel J.","family":"De Angelo","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Stone","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Nardi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2022,2,1]]},"reference":[{"issue":"4","key":"2022020116232017200_B1","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrc2091","article-title":"The impact of translocations and gene fusions on cancer causation","volume":"7","author":"Mitelman","year":"2007","journal-title":"Nat Rev Cancer."},{"issue":"2","key":"2022020116232017200_B2","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1021\/acsptsci.9b00019","article-title":"Molecular signatures of fusion proteins in cancer","volume":"2","author":"Latysheva","year":"2019","journal-title":"ACS Pharmacol Transl Sci."},{"key":"2022020116232017200_B3","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues.","author":"Swerdlow","year":"2017","edition":"Revised 4th ed"},{"issue":"1","key":"2022020116232017200_B4","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/PAP.0000000000000284","article-title":"The 2020 WHO classification of tumors of soft tissue: selected changes and new entities","volume":"28","author":"Choi","year":"2021","journal-title":"Adv Anat Pathol."},{"issue":"14","key":"2022020116232017200_B5","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","article-title":"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"Druker","year":"2001","journal-title":"N Engl J Med."},{"issue":"1","key":"2022020116232017200_B6","doi-asserted-by":"crossref","first-page":"e29904","DOI":"10.4161\/mco.29904","article-title":"Chromosomal rearrangements in cancer: detection and potential causal mechanisms","volume":"1","author":"Hasty","year":"2014","journal-title":"Mol Cell Oncol."},{"issue":"12","key":"2022020116232017200_B7","first-page":"4886","article-title":"Heterogeneity in the breakpoints in balanced rearrangements involving band 12p13 in hematologic malignancies identified by fluorescence in situ hybridization: TEL (ETV6 ) is involved in only one half","volume":"90","author":"Sato","year":"1997","journal-title":"Blood."},{"issue":"D1","key":"2022020116232017200_B8","doi-asserted-by":"crossref","first-page":"D265","DOI":"10.1093\/nar\/gkz991","article-title":"CDD\/SPARCLE: the conserved domain database in 2020","volume":"48","author":"Lu","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"2022020116232017200_B9","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.leukres.2012.04.010","article-title":"ETV6 fusion genes in hematological malignancies: a review","volume":"36","author":"De Braekeleer","year":"2012","journal-title":"Leuk Res."},{"issue":"1","key":"2022020116232017200_B10","doi-asserted-by":"crossref","first-page":"188389","DOI":"10.1016\/j.bbcan.2020.188389","article-title":"ETV6 gene aberrations in non-haematological malignancies: a review highlighting ETV6 associated fusion genes in solid tumors","volume":"1874","author":"Biswas","year":"2020","journal-title":"Biochim Biophys Acta Rev Cancer."},{"issue":"3","key":"2022020116232017200_B11","first-page":"1012","article-title":"ETV6 (TEL1) in blood cell development and malignancy","volume":"1","author":"Rasighaemi","year":"2014","journal-title":"J. Blood Disord."},{"issue":"1","key":"2022020116232017200_B12","first-page":"100","article-title":"Inhibition of the Abl protein-tyrosine kinase in\u00a0vitro and in\u00a0vivo by a 2-phenylaminopyrimidine derivative","volume":"56","author":"Buchdunger","year":"1996","journal-title":"Cancer Res."},{"key":"2022020116232017200_B13","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.critrevonc.2016.11.008","article-title":"Platelet-derived growth factor receptors (PDGFRs) fusion genes involvement in hematological malignancies","volume":"109","author":"Appiah-Kubi","year":"2017","journal-title":"Crit Rev Oncol Hematol."},{"issue":"41","key":"2022020116232017200_B14","doi-asserted-by":"crossref","first-page":"38627","DOI":"10.1074\/jbc.M204890200","article-title":"Definition of an inhibitory juxtamembrane WW-like domain in the platelet-derived growth factor beta receptor","volume":"277","author":"Irusta","year":"2002","journal-title":"J Biol Chem."},{"issue":"21","key":"2022020116232017200_B15","doi-asserted-by":"crossref","first-page":"8078","DOI":"10.1073\/pnas.0601192103","article-title":"Activation of FIP1L1-PDGFRalpha requires disruption of the juxtamembrane domain of PDGFRalpha and is FIP1L1-independent","volume":"103","author":"Stover","year":"2006","journal-title":"Proc Natl Acad Sci USA."},{"issue":"13","key":"2022020116232017200_B16","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMoa025217","article-title":"A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome","volume":"348","author":"Cools","year":"2003","journal-title":"N Engl J Med."},{"issue":"12","key":"2022020116232017200_B17","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/nm.3729","article-title":"Anchored multiplex PCR for targeted next-generation sequencing","volume":"20","author":"Zheng","year":"2014","journal-title":"Nat Med."},{"issue":"1","key":"2022020116232017200_B18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jmoldx.2018.08.003","article-title":"A Nanopore sequencing-based assay for rapid detection of gene fusions","volume":"21","author":"Jeck","year":"2019","journal-title":"J Mol Diagn."},{"issue":"6","key":"2022020116232017200_B19","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1101\/gr.229102","article-title":"The human genome browser at UCSC","volume":"12","author":"Kent","year":"2002","journal-title":"Genome Res."},{"key":"2022020116232017200_B20","doi-asserted-by":"crossref","first-page":"W597","DOI":"10.1093\/nar\/gks400","article-title":"ExPASy: SIB bioinformatics resource portal","volume":"40","author":"Artimo","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"2022020116232017200_B21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2018.11.022","article-title":"Clinicopathological and molecular features of SF3B1-mutated myeloproliferative neoplasms","volume":"86","author":"Boiocchi","year":"2019","journal-title":"Hum Pathol."},{"issue":"4","key":"2022020116232017200_B22","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jmoldx.2016.02.003","article-title":"Validation and implementation of a custom next-generation sequencing clinical assay for hematologic malignancies","volume":"18","author":"Kluk","year":"2016","journal-title":"J Mol Diagn."},{"issue":"4","key":"2022020116232017200_B23","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1365-2141.1995.tb05206.x","article-title":"A specific chromosome abnormality of t(4;12)(q11-12;p13) in CD7+\u00a0acute leukaemia","volume":"90","author":"Harada","year":"1995","journal-title":"Br J Haematol."},{"issue":"13","key":"2022020116232017200_B24","doi-asserted-by":"crossref","first-page":"10987","DOI":"10.18632\/oncotarget.23743","article-title":"Acute myeloid leukemia with t(4;12)(q12;p13): an aggressive disease with frequent involvement of PDGFRA and ETV6.","volume":"9","author":"Li","year":"2017","journal-title":"Oncotarget."},{"issue":"1","key":"2022020116232017200_B25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/bjh.13368","article-title":"4q12 translocations with GSX2 expression identify a CD7(+) acute myeloid leukaemia subset","volume":"171","author":"Di Giacomo","year":"2015","journal-title":"Br J Haematol."},{"issue":"5","key":"2022020116232017200_B26","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1182\/blood.V94.5.1820","article-title":"Fusion of a novel gene, BTL, to ETV6 in acute myeloid leukemias with a t(4;12)(q11-q12;p13)","volume":"94","author":"Cools","year":"1999","journal-title":"Blood."},{"issue":"1","key":"2022020116232017200_B27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2141.2007.06628.x","article-title":"Two novel imatinib-responsive PDGFRA fusion genes in chronic eosinophilic leukaemia","volume":"138","author":"Curtis","year":"2007","journal-title":"Br J Haematol."},{"issue":"3","key":"2022020116232017200_B28","doi-asserted-by":"crossref","first-page":"768","DOI":"10.3109\/10428194.2014.938330","article-title":"Imatinib non-responsive chronic eosinophilic leukemia with ETV6-PDGFRA fusion gene","volume":"56","author":"Yoshida","year":"2015","journal-title":"Leuk Lymphoma."},{"issue":"8","key":"2022020116232017200_B29","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/cyto.a.24302","article-title":"Phosflow assessment of PDGFRA phosphorylation state: a guide for tyrosine kinase inhibitor targeted therapy in hypereosinophilia patients","volume":"99","author":"Ranjbaran","year":"2021","journal-title":"Cytometry A."},{"issue":"2","key":"2022020116232017200_B30","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/ajcp\/aqaa208","article-title":"Myeloid\/lymphoid neoplasms associated with eosinophilia and rearrangements of PDGFRA, PDGFRB, or FGFR1 or with PCM1-JAK2","volume":"155","author":"Pozdnyakova","year":"2021","journal-title":"Am J Clin Pathol."},{"issue":"1","key":"2022020116232017200_B31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7243\/2052-434X-4-1","article-title":"A unique rearrangement of PDGFR\u03b1 and ETV6 in a patient with acute myeloid leukemia with myelodysplasia-related changes progressed from chronic myelomonocytic leukemia","volume":"4","author":"Koduru","year":"2016","journal-title":"Hematol. Leuk."},{"issue":"6","key":"2022020116232017200_B32","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.leukres.2008.11.016","article-title":"Validation of a new three-color fluorescence in situ hybridization (FISH) method to detect CHIC2 deletion, FIP1L1\/PDGFRA fusion and PDGFRA translocations","volume":"33","author":"Fink","year":"2009","journal-title":"Leuk Res."},{"issue":"2","key":"2022020116232017200_B33","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/BF00272988","article-title":"DNA polymerase alpha inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes","volume":"67","author":"Glover","year":"1984","journal-title":"Hum Genet."},{"issue":"1","key":"2022020116232017200_B34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bbagrm.2007.10.005","article-title":"Human chromosome fragility","volume":"1779","author":"Lukusa","year":"2008","journal-title":"Biochim Biophys Acta."},{"issue":"2-3","key":"2022020116232017200_B35","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000134197","article-title":"The ETV6, CDKN1B and D12S178 loci are involved in a segment commonly deleted in various 12p aberration in different hematological malignancies","volume":"72","author":"Wlodarska","year":"1996","journal-title":"Cytogenet Cell Genet."},{"issue":"8","key":"2022020116232017200_B36","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/leu.2008.34","article-title":"ETV6 mutations and loss in AML-M0","volume":"22","author":"Silva","year":"2008","journal-title":"Leukemia."},{"issue":"4","key":"2022020116232017200_B37","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1182\/blood.V86.4.1525.bloodjournal8641525","article-title":"TEL and KIP1 define the smallest region of deletions on 12p13 in hematopoietic malignancies","volume":"86","author":"Sato","year":"1995","journal-title":"Blood."},{"issue":"10","key":"2022020116232017200_B38","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1007\/s00277-020-04207-y","article-title":"Identification of a novel ETV6 truncated fusion gene in myeloproliferative neoplasm, unclassifiable with t(4;12)(q12;p13)","volume":"99","author":"Zhang","year":"2020","journal-title":"Ann Hematol."},{"issue":"1","key":"2022020116232017200_B39","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/gcc.10175","article-title":"A novel cryptic translocation t(12;17)(p13;p12-p13) in a secondary acute myeloid leukemia results in a fusion of the ETV6 gene and the antisense strand of the PER1 gene","volume":"37","author":"Murga Penas","year":"2003","journal-title":"Genes Chromosomes Cancer."},{"issue":"3","key":"2022020116232017200_B40","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/gcc.20081","article-title":"A new complex rearrangement involving the ETV6, LOC115548, and MN1 genes in a case of acute myeloid leukemia","volume":"41","author":"Belloni","year":"2004","journal-title":"Genes Chromosomes Cancer."},{"issue":"3","key":"2022020116232017200_B41","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1365-2141.2006.06020.x","article-title":"Fusion of ETV6 with an intronic sequence of the BAZ2A gene in a paediatric pre-B acute lymphoblastic leukaemia with a cryptic chromosome 12 rearrangement","volume":"133","author":"Panagopoulos","year":"2006","journal-title":"Br J Haematol."},{"issue":"6352","key":"2022020116232017200_B42","doi-asserted-by":"crossref","first-page":"eaan2507","DOI":"10.1126\/science.aan2507","article-title":"A pathology atlas of the human cancer transcriptome","volume":"357","author":"Uhlen","year":"2017","journal-title":"Science."},{"issue":"1","key":"2022020116232017200_B43","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.celrep.2018.03.050","article-title":"Driver fusions and their implications in the development and treatment of human cancers","volume":"23","author":"Gao","year":"2018","journal-title":"Cell Rep."},{"issue":"37","key":"2022020116232017200_B44","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1038\/onc.2014.406","article-title":"The landscape and therapeutic relevance of cancer-associated transcript fusions","volume":"34","author":"Yoshihara","year":"2015","journal-title":"Oncogene."},{"issue":"D1","key":"2022020116232017200_B45","doi-asserted-by":"crossref","first-page":"D1144","DOI":"10.1093\/nar\/gkx1018","article-title":"TumorFusions: an integrative resource for cancer-associated transcript fusions","volume":"46","author":"Hu","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"2022020116232017200_B46","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s10014-020-00377-9","article-title":"Glioblastomas harboring gene fusions detected by next-generation sequencing","volume":"37","author":"Woo","year":"2020","journal-title":"Brain Tumor Pathol."},{"issue":"1","key":"2022020116232017200_B47","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1186\/1471-2164-14-818","article-title":"Exploration of the gene fusion landscape of glioblastoma using transcriptome sequencing and copy number data","volume":"14","author":"Shah","year":"2013","journal-title":"BMC Genomics."},{"issue":"7793","key":"2022020116232017200_B48","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41586-020-1970-0","article-title":"Genomic basis for RNA alterations in cancer","volume":"578","author":"Calabrese","year":"2020","journal-title":"Nature."},{"issue":"19","key":"2022020116232017200_B49","doi-asserted-by":"crossref","first-page":"7030","DOI":"10.1128\/MCB.00322-06","article-title":"Functional analysis of p53 binding under differential stresses","volume":"26","author":"Krieg","year":"2006","journal-title":"Mol Cell Biol."},{"issue":"11","key":"2022020116232017200_B50","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1158\/0008-5472.CAN-19-3095","article-title":"PSF promotes ER-positive breast cancer progression via posttranscriptional regulation of ESR1 and SCFD2.","volume":"80","author":"Mitobe","year":"2020","journal-title":"Cancer Res."},{"issue":"12","key":"2022020116232017200_B51","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1038\/sj.leu.2403957","article-title":"A rare case of acute myeloid leukemia with a CHIC2-ETV6 fusiongen and multiple other molecular aberrations","volume":"19","author":"Kuchenbauer","year":"2005","journal-title":"Leukemia."},{"issue":"2","key":"2022020116232017200_B52","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1111\/ijlh.12450","article-title":"Transcriptional activation of platelet-derived growth factor receptor \u03b1 and GS homeobox 2 resulting from E26 transformation-specific variant 6 translocation in a case of acute myeloid leukemia with t(4;12)(q12;p13)","volume":"38","author":"Abe","year":"2016","journal-title":"Int J Lab Hematol."},{"issue":"5","key":"2022020116232017200_B53","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1182\/blood.V99.5.1776","article-title":"Evidence for position effects as a variant ETV6-mediated leukemogenic mechanism in myeloid leukemias with a t(4;12)(q11-q12;p13) or t(5;12)(q31;p13)","volume":"99","author":"Cools","year":"2002","journal-title":"Blood."},{"issue":"4","key":"2022020116232017200_B54","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1073\/pnas.1008824108","article-title":"Homeobox genes Gsx1 and Gsx2 differentially regulate telencephalic progenitor maturation","volume":"108","author":"Pei","year":"2011","journal-title":"Proc Natl Acad Sci USA."},{"issue":"1","key":"2022020116232017200_B55","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3892\/ol.2015.3241","article-title":"GSH2 promoter methylation in pancreatic cancer analyzed by quantitative methylation-specific polymerase chain reaction","volume":"10","author":"Gao","year":"2015","journal-title":"Oncol Lett."},{"issue":"7","key":"2022020116232017200_B56","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1158\/0008-5472.CAN-09-3631","article-title":"CpG island hypermethylation in human astrocytomas","volume":"70","author":"Wu","year":"2010","journal-title":"Cancer Res."},{"issue":"1","key":"2022020116232017200_B57","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1159\/000489954","article-title":"Integrative analysis of DNA methylation and gene expression identify a three-gene signature for predicting prognosis in lower-grade gliomas","volume":"47","author":"Zeng","year":"2018","journal-title":"Cell Physiol Biochem."},{"issue":"7","key":"2022020116232017200_B58","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1038\/bcj.2013.20","article-title":"Identification of GSX2 and AF10 as NUP98 partner genes in myeloid malignancies","volume":"3","author":"Soler","year":"2013","journal-title":"Blood Cancer J."},{"issue":"D1","key":"2022020116232017200_B59","doi-asserted-by":"crossref","first-page":"D941","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: the Catalogue Of Somatic Mutations In Cancer","volume":"47","author":"Tate","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"12","key":"2022020116232017200_B60","doi-asserted-by":"crossref","first-page":"13216","DOI":"10.1096\/fj.201900366R","article-title":"LNX1 contributes to tumor growth by down-regulating p53 stability","volume":"33","author":"Park","year":"2019","journal-title":"FASEB J."},{"issue":"11","key":"2022020116232017200_B61","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/j.biocel.2005.02.028","article-title":"Characterization of human LNX, a novel ligand of Numb protein X that is downregulated in human gliomas","volume":"37","author":"Chen","year":"2005","journal-title":"Int J Biochem Cell Biol."},{"issue":"21","key":"2022020116232017200_B62","doi-asserted-by":"crossref","first-page":"5393","DOI":"10.1182\/bloodadvances.2020003007","article-title":"Whole transcriptome sequencing detects a large number of novel fusion transcripts in patients with AML and MDS","volume":"4","author":"Stengel","year":"2020","journal-title":"Blood Adv."},{"issue":"2","key":"2022020116232017200_B63","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0165-4608(99)00060-6","article-title":"A new translocation, t(2;4;12)(p21;q12;p13), in CD7-positive acute myeloid leukemia: a variant form of t(4;12)","volume":"114","author":"Hamaguchi","year":"1999","journal-title":"Cancer Genet Cytogenet."},{"issue":"2","key":"2022020116232017200_B64","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/gcc.1127","article-title":"Identification of new translocations involving ETV6 in hematologic malignancies by fluorescence in situ hybridization and spectral karyotyping","volume":"31","author":"Odero","year":"2001","journal-title":"Genes Chromosomes Cancer."},{"key":"2022020116232017200_B65","doi-asserted-by":"crossref","article-title":"A new case of t(4;12)(q12;p13) in a secondary acute myeloid leukemia with review of literature","author":"Heaton","DOI":"10.4267\/2042\/46059"},{"issue":"2","key":"2022020116232017200_B66","doi-asserted-by":"crossref","first-page":"133","DOI":"10.5045\/br.2016.51.2.133","article-title":"Acute myeloid leukemia with t(4;12)(q12;p13): report of 2 cases","volume":"51","author":"Kim","year":"2016","journal-title":"Blood Res."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/3\/818\/1866073\/advancesadv2021005280.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/3\/818\/1866073\/advancesadv2021005280.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T12:06:52Z","timestamp":1643717212000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/6\/3\/818\/477073\/t-4-12-q12-p13-ETV6-rearranged-AML-without"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,8]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,1,8]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021005280","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,8]]}}}